Prognostic value of disease risk score versus gait speed in older adults with lymphoma. Leuk Lymphoma. 2021 Jun 11; 1-8.
View in:
PubMed
Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close? Curr Hematol Malig Rep. 2021 04; 16(2):117-125.
View in:
PubMed
Prevalence and Tolerance of Prognostic Uncertainty Among Thoracic Oncologists. Oncologist. 2021 Apr 12.
View in:
PubMed
Strategies for introducing palliative care in the management of relapsed or refractory aggressive lymphomas. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):148-153.
View in:
PubMed
Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. Cancer. 2021 Mar 15; 127(6):875-883.
View in:
PubMed
A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients. Leukemia. 2021 04; 35(4):1064-1072.
View in:
PubMed
Patients with haematological malignancies should not have to choose between transfusions and hospice care. Lancet Haematol. 2020 May; 7(5):e418-e424.
View in:
PubMed
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma. Blood Adv. 2020 03 10; 4(5):858-867.
View in:
PubMed
Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups With Blood Cancer Patients and Bereaved Caregivers. J Pain Symptom Manage. 2020 06; 59(6):1195-1203.e4.
View in:
PubMed
Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization. Cancer. 2020 02 01; 126(3):515-522.
View in:
PubMed
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation. Blood. 2019 07 04; 134(1):22-29.
View in:
PubMed
How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists. J Palliat Med. 2019 06; 22(6):677-684.
View in:
PubMed
Meaningful changes in end-of-life care among patients with myeloma. Haematologica. 2018 08; 103(8):1380-1389.
View in:
PubMed
Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival. Cancer Epidemiol Biomarkers Prev. 2018 03; 27(3):345-347.
View in:
PubMed
Septic Episodes in a Premature Infant After In Utero Exposure to Rituximab. Pediatrics. 2017 Sep; 140(3).
View in:
PubMed
Why are patients with blood cancers more likely to die without hospice? Cancer. 2017 Sep 01; 123(17):3377-3384.
View in:
PubMed
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 07 11; 30(1):183.
View in:
PubMed
Barriers to Quality End-of-Life Care for Patients With Blood Cancers. J Clin Oncol. 2016 09 10; 34(26):3126-32.
View in:
PubMed
Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 08; 22(8):1504-1510.
View in:
PubMed
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 04 11; 29(4):574-586.
View in:
PubMed
Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life. J Pain Symptom Manage. 2016 08; 52(2):161-9.
View in:
PubMed
Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes. Br J Haematol. 2016 06; 173(5):713-21.
View in:
PubMed
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database. Cancer. 2016 Apr 15; 122(8):1209-15.
View in:
PubMed
Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists. JAMA Intern Med. 2016 Feb; 176(2):263-5.
View in:
PubMed
A Policy Prescription for Hospice Care. JAMA. 2016 Jan 19; 315(3):257-8.
View in:
PubMed
Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability. J Natl Cancer Inst. 2016 Jan; 108(1).
View in:
PubMed
Novel data sharing between a comprehensive cancer center and a private payer to better understand care at the end of life. J Clin Oncol. 2014 Oct 20; 32(30_suppl):1.
View in:
PubMed
End-of-life care for blood cancers: a series of focus groups with hematologic oncologists. J Oncol Pract. 2014 Nov; 10(6):e396-403.
View in:
PubMed
Early lymphoid lesions: conceptual, diagnostic and clinical challenges. Haematologica. 2014 Sep; 99(9):1421-32.
View in:
PubMed
Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients. Leuk Lymphoma. 2015 Mar; 56(3):716-24.
View in:
PubMed
Reply to quality control of bone marrow aspirates: additional steps toward a safer and more efficient procedure. Cancer. 2014 May 01; 120(9):1442.
View in:
PubMed
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014 Feb 27; 123(9):1293-6.
View in:
PubMed
Improving the quality of bone marrow assessment: Impact of operator techniques and use of a specimen preparation checklist. Cancer. 2013 Oct 01; 119(19):3472-8.
View in:
PubMed
Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia. 2013 Apr; 27(4):968-71.
View in:
PubMed
An extreme example of focal bone marrow involvement in acute myeloid leukemia. Am J Hematol. 2013 Apr; 88(4):335-6.
View in:
PubMed
Safety and effectiveness of oxaliplatin-based chemotherapy regimens in adults 75 years and older with colorectal cancer. Clin Colorectal Cancer. 2013 Mar; 12(1):62-9.
View in:
PubMed
Survival of a patient with anaplastic thyroid cancer following intensity-modulated radiotherapy and sunitinib--a case report. Anticancer Res. 2012 May; 32(5):1743-6.
View in:
PubMed